Neermann Joerg 4

What Happened
Joerg Neermann, a director of IMMUNIC, Inc. (IMUX), was granted a derivative award on 2026-07-05 covering 25,370 shares. The filing lists the acquisition price as $0.00 and classifies the transaction as a derivative award (an option). This is a grant/award — not an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-05; Form 4 filed: 2026-07-07 (filed two days after the transaction).
• Shares/units granted: 25,370 derivative securities; dollar amount at grant shown as $0.00.
• Vesting: Footnote F1 — the option vests in monthly increments over one year from the grant date.
• Shares owned after the transaction: not specified in the provided filing data.
• Filing timeliness: appears timely (filed within two business days of the grant).
• Nature of transaction: derivative award (option grant) — not an immediate cash transaction or sale.

Context
This was an equity compensation grant to a board member, which is commonly used to align interests with shareholders. Because it’s a derivative award that vests over time, it does not represent immediate buying or selling of stock and should not be read as a direct market purchase. The filing does not show any exercise or sale tied to this grant.